Generation of a Replication-Competent, Propagation-Deficient Virus Vector Based on the Transmissible Gastroenteritis Coronavirus Genome

ABSTRACT Replication-competent propagation-deficient virus vectors based on the transmissible gastroenteritis coronavirus (TGEV) genome that are deficient in the essential E gene have been developed by complementation within E+ packaging cell lines. Cell lines expressing the TGEV E protein were established using the noncytopathic Sindbis virus replicon pSINrep21. In addition, cell lines stably expressing the E gene under the CMV promoter have been developed. The Sindbis replicon vector and the ectopic TGEV E protein did not interfere with the rescue of infectious TGEV from full-length cDNA. Recombinant TGEV deficient in the nonessential 3a and 3b genes and the essential E gene (rTGEV-Δ3abΔE) was successfully rescued in these cell lines. rTGEV-Δ3abΔE reached high titers (107 PFU/ml) in baby hamster kidney cells expressing porcine aminopeptidase N (BHK-pAPN), the cellular receptor for TGEV, using Sindbis replicon and reached titers up to 5 × 105 PFU/ml in cells stably expressing E protein under the control of the CMV promoter. The virus titers were proportional to the E protein expression level. The rTGEV-Δ3abΔE virions produced in the packaging cell line showed the same morphology and stability under different pHs and temperatures as virus derived from the full-length rTGEV genome, although a delay in virus assembly was observed by electron microscopy and virus titration in the complementation system in relation to the wild-type virus. These viruses were stably grown for >10 passages in the E+ packaging cell lines. The availability of packaging cell lines will significantly facilitate the production of safe TGEV-derived vectors for vaccination and possibly gene therapy.

[1]  R. Baric,et al.  Establishing a genetic recombination map for murine coronavirus strain A59 complementation groups , 1990, Virology.

[2]  F. Falkner,et al.  Retroviral Vectors Produced in the Cytoplasmic Vaccinia Virus System Transduce Intron-Containing Genes , 2002, Journal of Virology.

[3]  J. Wilson,et al.  Gene therapy: adenovirus vectors. , 1993, Current opinion in genetics & development.

[4]  A. Gultyaev,et al.  Arterivirus discontinuous mRNA transcription is guided by base pairing between sense and antisense transcription-regulating sequences. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[5]  H. Laude,et al.  Coronavirus Pseudoparticles Formed with Recombinant M and E Proteins Induce Alpha Interferon Synthesis by Leukocytes , 1998, Journal of Virology.

[6]  Y. Ron,et al.  An inducible packaging cell system for safe, efficient lentiviral vector production in the absence of HIV-1 accessory proteins. , 2001, Virology.

[7]  T. Wang,et al.  The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus. , 2001, The Journal of general virology.

[8]  L. Enjuanes,et al.  Two Types of Virus-Related Particles Are Found during Transmissible Gastroenteritis Virus Morphogenesis , 1998, Journal of Virology.

[9]  Tal Kafri,et al.  A Packaging Cell Line for Lentivirus Vectors , 1999, Journal of Virology.

[10]  Stabilization of a Full-Length Infectious cDNA Clone of Transmissible Gastroenteritis Coronavirus by Insertion of an Intron , 2002, Journal of Virology.

[11]  A. Miller,et al.  Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production , 1986, Molecular and cellular biology.

[12]  R. Johnston,et al.  Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo. , 1997, Virology.

[13]  L. Enjuanes,et al.  The Membrane M Protein Carboxy Terminus Binds to Transmissible Gastroenteritis Coronavirus Core and Contributes to Core Stability , 2001, Journal of Virology.

[14]  A. Maeda,et al.  Membrane Topology of Coronavirus E Protein , 2001, Virology.

[15]  DJ Garwes Transmissible gastroenteritis , 1988, Veterinary Record.

[16]  G. Nemerow,et al.  Complementation of a fibre mutant adenovirus by packaging cell lines stably expressing the adenovirus type 5 fibre protein. , 1998, The Journal of general virology.

[17]  T. Dubensky,et al.  Stable alphavirus packaging cell lines for Sindbis virus and Semliki Forest virus-derived vectors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[18]  H. Vennema,et al.  Characterization of the Coronavirus Mouse Hepatitis Virus Strain A59 Small Membrane Protein E , 2000, Journal of Virology.

[19]  M. Bullido,et al.  Critical epitopes in transmissible gastroenteritis virus neutralization. , 1986, Advances in experimental medicine and biology.

[20]  F. Fischer,et al.  Analysis of Constructed E Gene Mutants of Mouse Hepatitis Virus Confirms a Pivotal Role for E Protein in Coronavirus Assembly , 1998, Journal of Virology.

[21]  E. Frolova,et al.  Sindbis virus replicons and Sindbis virus: assembly of chimeras and of particles deficient in virus RNA , 1997, Journal of virology.

[22]  S. Schlesinger,et al.  Complementation between Sindbis viral RNAs produces infectious particles with a bipartite genome. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Claude M. Fauquet,et al.  The classification and nomenclature of viruses , 1976, Archives of Virology.

[24]  L. Enjuanes,et al.  Organization of Two Transmissible Gastroenteritis Coronavirus Membrane Protein Topologies within the Virion and Core , 2001, Journal of Virology.

[25]  J. M. González,et al.  Engineering the largest RNA virus genome as an infectious bacterial artificial chromosome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Izeta,et al.  Transcription Regulatory Sequences and mRNA Expression Levels in the Coronavirus Transmissible Gastroenteritis Virus , 2002, Journal of Virology.

[27]  R. Baric,et al.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. An,et al.  Induction of Apoptosis in Murine Coronavirus-Infected Cultured Cells and Demonstration of E Protein as an Apoptosis Inducer , 1999, Journal of Virology.

[29]  R. Dornburg,et al.  Improved retroviral packaging lines derived from spleen necrosis virus. , 1995, Virology.

[30]  G. Dulac,et al.  Towards the Control of Emerging Bluetongue Disease , 1993 .

[31]  S. Sawicki,et al.  A new model for coronavirus transcription. , 1998, Advances in experimental medicine and biology.

[32]  D. Brian,et al.  Downstream Sequences Influence the Choice between a Naturally Occurring Noncanonical and Closely Positioned Upstream Canonical Heptameric Fusion Motif during Bovine Coronavirus Subgenomic mRNA Synthesis , 2001, Journal of Virology.

[33]  R. Baric,et al.  Heterologous Gene Expression from Transmissible Gastroenteritis Virus Replicon Particles , 2002, Journal of Virology.

[34]  C. Rice,et al.  Alphavirus-based expression vectors: strategies and applications. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[35]  R. Hall,et al.  Efficient trans-Complementation of the Flavivirus Kunjin NS5 Protein but Not of the NS1 Protein Requires Its Coexpression with Other Components of the Viral Replicase , 1999, Journal of Virology.

[36]  B. Delmas,et al.  Further characterization of aminopeptidase-N as a receptor for coronaviruses. , 1993, Advances in experimental medicine and biology.

[37]  M. Ataai,et al.  Production of viral vectors for gene therapy applications. , 2000, Current opinion in biotechnology.

[38]  B. Schnierle,et al.  A packaging cell line generating CD4-specific retroviral vectors for efficient gene transfer into primary human T-helper lymphocytes. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  H. Vennema,et al.  Nucleocapsid-independent assembly of coronavirus-like particles by co-expression of viral envelope protein genes. , 1996, The EMBO journal.

[40]  E. G. Westaway,et al.  trans-Complementation Analysis of the Flavivirus Kunjin ns5 Gene Reveals an Essential Role for Translation of Its N-Terminal Half in RNA Replication , 1999, Journal of Virology.

[41]  R. Baric,et al.  Evidence for variable rates of recombination in the MHV genome , 1992, Virology.

[42]  C. Rice,et al.  Selection of RNA Replicons Capable of Persistent Noncytopathic Replication in Mammalian Cells , 1999, Journal of Virology.

[43]  C. Sánchez,et al.  Complete Genome Sequence of Transmissible Gastroenteritis Coronavirus PUR46-MAD Clone and Evolution of the Purdue Virus Cluster , 2004, Virus Genes.

[44]  B. Hogue,et al.  The 9-kDa hydrophobic protein encoded at the 3′ end of the porcine transmissible gastroenteritis coronavirus genome is membrane-associated , 1992, Virology.

[45]  A. Miller,et al.  Retrovirus packaging cells based on 10A1 murine leukemia virus for production of vectors that use multiple receptors for cell entry , 1996, Journal of virology.

[46]  L. Enjuanes,et al.  Molecular Basis of Transmissible Gastroenteritis Virus Epidemiology , 1995 .

[47]  M. Lai,et al.  The Molecular Biology of Coronaviruses , 1997, Advances in Virus Research.

[48]  C. Rice,et al.  trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication , 1997, Journal of virology.

[49]  H. Laude,et al.  Transmissible Gastroenteritis Coronavirus Induces Programmed Cell Death in Infected Cells through a Caspase-Dependent Pathway , 1998, Journal of Virology.

[50]  H. Laude,et al.  TGEV corona virus ORF4 encodes a membrane protein that is incorporated into virions , 1992, Virology.

[51]  A. Maeda,et al.  Release of Coronavirus E Protein in Membrane Vesicles from Virus-Infected Cells and E Protein-Expressing Cells , 1999, Virology.